Neurogenic erectile dysfunction

Clinical Autonomic Research

Volumn 11, Issue 5, 2001, Pages 285-294

  Lue, T F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Erectile dysfunction; Multiple sclerosis; Parkinson disease; Radical prostatectomy; Spinal cord injury

Indexed keywords

NEUROTRANSMITTER; PROSTAGLANDIN E1; PROSTAVASIN; SILDENAFIL;

ALZHEIMER DISEASE; ANGIOGENESIS; DRUG COST; ENDOCRINE FUNCTION; EPILEPSY; ERECTILE DYSFUNCTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTERVERTEBRAL DISK HERNIA; MALE; MULTIPLE SCLEROSIS; NEUROANATOMY; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PENIS ERECTION; PENIS PROSTHESIS; PSYCHOGENESIS; PSYCHOSOCIAL CARE; REVIEW; SHY DRAGER SYNDROME; SPINA BIFIDA; SPINAL CORD INJURY;

EID: 0035179491     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02332973     Document Type: Review

References (98)

1. Neuroanatomic correlates of visually evoked sexual arousal in human males
2. Brain processing of visual sexual stimuli in human males
3. BOLD fMRI evaluation of normal female sexual arousal response: Sites of cerebral activation correlated with subjective and objective measures of arousal
4. Neurophysiology of penile erection
5. Neural control of penile erection
6. New prospectives in the treatment of male erectile dysfunction
7. Impotence following radical prostatectomy: Insight into etiology and prevention
8. An anatomic explanation for bladder dysfunction following rectal and uterine surgery
9. Detailed anatomy of penile neurovascular structures: Surgical significance
10. Physiology of penile erection
11. Regulation of adrenergic activity in penile corpus cavernosum
12. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms
13. Functional response of cavernosal tissue to distension
14. Endothelin-1-induced alterations in phenylephrine-induced contractile responses are largely additive in physiologically diverse rabbit vasculature
15. Tissue angiotensin II as a modulator of erectile function, I. Angiotensin peptide content, secretion and effects in the corpus cavernosum
16. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
17. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
18. Erectile dysfunction
19. Neurologic erectile dysfunction
20. Parkinson's disease: A major hypokinetic basal ganglia disorder
21. Autonomic dysfunction in men with Parkinson's disease
22. Sexual dysfunction in Parkinson's disease
23. Sexual function in patients with Parkinson's disease
24. Physiology of erection
25. The incidence and correlates of erectile problems in patients with Alzheimer's disease
26. Alterations of sexual behavior in temporal lobe epilepsy
27. Seizure control with clomiphene therapy. A case report
28. Sex hormones and pituitary function in male epileptics with altered or normal sexuality
29. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial with clomiphene citrate
30. Multiple sclerosis, I. Overview, pathophysiology, diagnostic evaluation, and clinical parameters
31. Sexual dysfunction in multiple sclerosis
32. Neurobiology of erectile dysfunction in multiple sclerosis
33. Inherited peripheral neuropathy
34. Bulbocavernous reflex studies and autonomic testing in the diagnosis of erectile dysfunction
35. Neurophysiological testing in erectile dysfunction
36. Late neurologic dysfunction in adult lumbosacral lipoma with tethered cord
37. Tethered spinal cord: The effect of neurosurgery on the lower urinary tract and male sexual function
38. Erectile dysfunction in spina bifida is treatable
39. Impotence in the low-back syndrome
40. Early relief of erectile dysfunction after laser decompression of herniated lumbar disc
41. Occult lumbar disk causing impotency
42. Spinal cord injury
43. Sexual potency in elderly men before and after prostatectomy
44. Impotence following radical prostatectomy: Insight into etiology and prevention
45. Radical prostatectomy, preservation of sexual function, cancer control. The controversy
46. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique
47. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer
48. Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer
49. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation
50. Diabetic sexual dysfunction
51. Diabetic impotence
52. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle
53. Dysfunctional penile cholinergic nerves in diabetic impotent men
54. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
55. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model
56. Selective nitrergic neurode-generation in diabetes mellitus - A nitric oxide-dependent phenomenon
57. Effect of intensive diabetes management on the development and progression of neuropathy
58. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973
59. Genitourinary dysfunction in multiple system atrophy: Clinical features and treatment in 62 cases
60. Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction
61. Computerized classification of corpus cavernosum electromyogram signals by the use of discriminant analysis and artificial neural networks to support diagnosis of erectile dysfunction
62. New developments in the diagnosis of diabetic neuropathy
63. Oral sildenafil in the treatment of erectile dysfunction
64. Sildenafil for the treatment of erectile dysfunction in men with diabetes: A randomized controlled trial
65. Sildenafil citrate (Viagra) treatment in patients with diabetes mellitus
66. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease
67. A two-part pilot study of sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury
68. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury
69. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
70. Role of Viagra after radical prostatectomy
71. Vacuum devices for erectile impotence
72. Noninvasive device to produce and maintain an erection-like state
73. Vacuum erection device in spinal cord injured men: Patient and partner satisfaction
74. Unusual complications of the vacuum erection device
75. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
76. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra)
77. Treatment of men with erectile dysfunction with transurethral alprostadil
78. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury
79. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy
80. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients
81. A simplified pharmacologic erection program for patients with spinal cord injury
82. Intracavernosal therapy
83. Pharmacotherapeutic advances in the treatment of erectile dysfunction
84. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: A multicenter double-blind placebo-controlled study
85. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy: 18-Month follow up
86. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction
87. Long-term results of penile prosthetic implants
88. Complications of penile prostheses and complex implantations
89. Long-term experience with salvage of infected penile implants
90. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat
91. Possible molecular mechanisms of cryoablation-induced impotence in a rat model
92. Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia
93. IGF-I and TGF-beta2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats
94. Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats
95. Neurotrophic factors in the therapy of diabetic neuropathy
96. Nerve growth factor enhances peripheral nerve regeneration in non-human primates
97. The effect of adeno-associated virus-mediated brain-derived neurotrophic factor in an animal model for neurogenic impotence
98. Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips